McGill University researchers have demonstrated that AMPA receptors (AMPARs), which mediate fast excitatory neurotransmission ...

Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

The wedding comes just weeks after Thurston, who starred in season 17 of "The Bachelorette," revealed in an emotional ...

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple ...

In recent years, many engineers have been trying to develop hardware components that could emulate the functions of various ...

Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved promising weight reduction in a ...

Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more effectiveness than Ozempic and comes at a lower cost. Experts believe it ...

Research shows that glucagon-like peptide-1 receptor agonists (or GLP-1s – think Ozempic or similar medications) are changing ...

IMAGINE a juicy strawberry or your favourite dark chocolate tasting like it’s the first time you’ve tried them. For smokers, ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders through targeted drug delivery.

Microdosing psychedelics like LSD and psilocybin shows potential for enhancing mental health, creativity, and cognitive ...

Zerodha’s Nithin Kamath sparks debate on Ozempic, Mounjaro & their game-changing impact on obesity, addiction & industries. Is India ready for this shift?